Tapewire

Nasdaq · USD

TELA

TELA Bio, Inc.

Export transactions ↓
Tapewire entity
7381
SEC CIK
0001561921
Parsed reports
268

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202620
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2021 Filed May 18, 2021 17:00 UTC PurchaseCommon Stock, par value $0.001 per share 7,500 $12.45 $93,375.00
Disclosure

SEC source: 0000899243-21-019769 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,673,055

F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 3,050 shares and Fund 2-A purchased 4,450 shares of the amount shown purchased on 5/14/2021.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 13, 2021 Filed May 14, 2021 14:08 UTC PurchaseCommon Stock, par value $0.001 per share 10,000 $11.87 $118,700.00
Disclosure

SEC source: 0000899243-21-019493 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,665,555

F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Fund 2 purchased 2,033 shares and 4,066 shares on 5/12/2021 and 5/13/2021, respectively, and Fund 2-A purchased 2,967 shares and 5,934 shares on 5/12/2021 and 5/13/2021, respectively.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 12, 2021 Filed May 14, 2021 14:08 UTC PurchaseCommon Stock, par value $0.001 per share 5,000 $12.49 $62,450.00
Disclosure

SEC source: 0000899243-21-019493 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,655,555

F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Fund 2 purchased 2,033 shares and 4,066 shares on 5/12/2021 and 5/13/2021, respectively, and Fund 2-A purchased 2,967 shares and 5,934 shares on 5/12/2021 and 5/13/2021, respectively.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 11, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 7,500 $12.75 $95,625.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 18

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,650,555

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 10, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 7,500 $12.93 $96,975.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 17

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,643,055

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 07, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 7,500 $13.15 $98,625.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 16

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,635,555

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 06, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 6,499 $13.15 $85,461.85
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 15

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,628,055

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
May 05, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 7,500 $13.28 $99,600.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 14

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,621,556

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 28, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 200 $13.41 $2,682.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 13

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,614,056

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 27, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 15,000 $13.49 $202,350.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 12

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,613,856

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 23, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 5,000 $13.51 $67,550.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 11

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,598,856

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 22, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 5,000 $13.54 $67,700.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 10

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,593,856

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 21, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 365 $13.59 $4,960.35
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 9

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,588,856

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 20, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 4,678 $13.54 $63,340.12
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 8

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,588,491

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 19, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 625 $13.61 $8,506.25
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 7

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,583,813

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 12, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 2,893 $13.57 $39,258.01
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 6

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,583,188

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
April 08, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 206 $13.67 $2,816.02
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 5

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,580,295

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 14:42 UTC
Murphy Peter C.Chief Commercial Officer
GrantCommon Stock 2,298 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000298 · edgar.xml · nonDerivative · entry 1

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,498

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 14:43 UTC
KOBLISH ANTONYDirector · Chief Executive Officer
GrantCommon Stock 5,439 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000300 · edgar.xml · nonDerivative · entry 1

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,424

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 18:43 UTC
Greenhalgh Ellis SkottChief Technology Officer
GrantCommon Stock 2,789 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000299 · edgar.xml · nonDerivative · entry 1

Greenhalgh Ellis Skott · CIK 0001790671 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,899

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 18:41 UTC
Brennan NoraChief Financial Officer
GrantCommon Stock 2,928 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000297 · edgar.xml · nonDerivative · entry 1

Brennan Nora · CIK 0001790215 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,696

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
March 26, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 37,851 $12.88 $487,520.88
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 4

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,580,089

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 25, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 5,000 $13.11 $65,550.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,542,238

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 24, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 2,660 $13.94 $37,080.40
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,537,238

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
March 23, 2021 Filed May 13, 2021 16:49 UTC PurchaseCommon Stock, par value $0.001 per share 10,000 $13.79 $137,900.00
Disclosure

SEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,534,578

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:24 UTC
Murphy Peter C.Chief Commercial Officer
GrantStock Option (right to buy) · Derivative 20,400 $0.00 Strike: $16.99 $0.00
Disclosure

SEC source: 0001192482-21-000188 · edgar.xml · derivative · entry 2

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,400

Underlying: Common Stock · 20,400 shares

Expires 2031-02-24

F2 · derivative.exercise_date: The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:24 UTC
Murphy Peter C.Chief Commercial Officer
GrantCommon Stock 11,200 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000188 · edgar.xml · nonDerivative · entry 1

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,200

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:27 UTC
PERSENAIRE MAARTENChief Medical Officer
GrantStock Option (right to buy) · Derivative 21,800 $0.00 Strike: $16.99 $0.00
Disclosure

SEC source: 0001192482-21-000190 · edgar.xml · derivative · entry 2

PERSENAIRE MAARTEN · CIK 0001207313 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,800

Underlying: Common Stock · 21,800 shares

Expires 2031-02-24

F2 · derivative.exercise_date: The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:27 UTC
PERSENAIRE MAARTENChief Medical Officer
GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000190 · edgar.xml · nonDerivative · entry 1

PERSENAIRE MAARTEN · CIK 0001207313 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,887

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:31 UTC
KOBLISH ANTONYDirector · Chief Executive Officer
GrantCommon Stock (right to buy) · Derivative 63,600 $0.00 Strike: $16.99 $0.00
Disclosure

SEC source: 0001192482-21-000192 · edgar.xml · derivative · entry 2

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,600

Underlying: Common Stock · 63,600 shares

Expires 2031-02-24

F2 · derivative.exercise_date: The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 17:31 UTC
KOBLISH ANTONYDirector · Chief Executive Officer
GrantCommon Stock 34,900 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000192 · edgar.xml · nonDerivative · entry 1

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,985

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:25 UTC
Brennan NoraChief Financial Officer
GrantStock Option (right to buy) · Derivative 20,100 $0.00 Strike: $16.99 $0.00
Disclosure

SEC source: 0001192482-21-000189 · edgar.xml · derivative · entry 2

Brennan Nora · CIK 0001790215 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 20,100 shares

Expires 2031-02-24

F2 · derivative.exercise_date: The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:25 UTC
Brennan NoraChief Financial Officer
GrantCommon Stock 11,100 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000189 · edgar.xml · nonDerivative · entry 1

Brennan Nora · CIK 0001790215 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,768

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:29 UTC
Greenhalgh Ellis SkottChief Technology Officer
GrantStock Option (right to buy) · Derivative 21,000 $0.00 Strike: $16.99 $0.00
Disclosure

SEC source: 0001192482-21-000191 · edgar.xml · derivative · entry 2

Greenhalgh Ellis Skott · CIK 0001790671 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2031-02-24

F2 · derivative.exercise_date: The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:29 UTC
Greenhalgh Ellis SkottChief Technology Officer
GrantCommon Stock 11,600 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000191 · edgar.xml · nonDerivative · entry 1

Greenhalgh Ellis Skott · CIK 0001790671 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,110

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.

Read SEC document
February 04, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 2,822 $14.29 $40,326.38
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 10

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,524,578

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 02, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 250 $14.08 $3,520.00
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 9

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,521,756

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
February 01, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 1,119 $14.16 $15,845.04
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 8

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,521,506

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 29, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 7,760 $13.93 $108,096.80
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 7

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,520,387

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 28, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 13,950 $13.68 $190,836.00
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 6

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,512,627

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 27, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 5,000 $14.03 $70,150.00
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 5

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,498,677

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 26, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 1,544 $14.24 $21,986.56
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 4

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,493,677

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 15, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 763 $13.88 $10,590.44
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 3

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,492,133

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 14, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 9,075 $13.96 $126,687.00
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 2

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,491,370

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
January 13, 2021 Filed Feb 23, 2021 12:47 UTC PurchaseCommon Stock, par value $0.001 per share 7,002 $13.90 $97,327.80
Disclosure

SEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,482,295

F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document
August 28, 2020 Filed Feb 16, 2024 16:10 UTC
EW HEALTHCARE PARTNERS FUND 2, L.P.10% owner · See Remarks
PurchaseCommon Stock, par value $0.001 per share 100 $12.85 $1,285.00
Disclosure

SEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 26

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 1,475,293

F42 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 41 shares of the amount shown above and EW Fund 2-A purchased 59 shares of the amount shown above.

Read SEC document
August 14, 2020 Filed Feb 16, 2024 16:10 UTC
EW HEALTHCARE PARTNERS FUND 2, L.P.10% owner · See Remarks
PurchaseCommon Stock, par value $0.001 per share 9,179 $12.95 $118,868.05
Disclosure

SEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 25

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 1,475,193

F41 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,732 shares of the amount shown above and EW Fund 2-A purchased 5,447 shares of the amount shown above.

Read SEC document
August 11, 2020 Filed Feb 16, 2024 16:10 UTC
EW HEALTHCARE PARTNERS FUND 2, L.P.10% owner · See Remarks
PurchaseCommon Stock, par value $0.001 per share 821 $12.95 $10,631.95
Disclosure

SEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 24

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 1,466,014

F40 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 334 shares of the amount shown above and EW Fund 2-A purchased 487 shares of the amount shown above.

Read SEC document
August 04, 2020 Filed Feb 16, 2024 16:10 UTC
EW HEALTHCARE PARTNERS FUND 2, L.P.10% owner · See Remarks
PurchaseCommon Stock, par value $0.001 per share 10,200 $12.72 $129,744.00
Disclosure

SEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 23

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 1,465,193

F39 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,148 shares of the amount shown above and EW Fund 2-A purchased 6,052 shares of the amount shown above.

Read SEC document
August 03, 2020 Filed Feb 16, 2024 16:10 UTC
EW HEALTHCARE PARTNERS FUND 2, L.P.10% owner · See Remarks
PurchaseCommon Stock, par value $0.001 per share 1,400 $11.86 $16,604.00
Disclosure

SEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 22

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Remarks

Disclosed balance after: 1,454,993

F38 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 569 shares of the amount shown above and EW Fund 2-A purchased 831 shares of the amount shown above.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.